Article citationsMore>>

C. Gridelli, F. De Marinis, M. Di Maio, et al., “Gefitinib as First-Line Treatment for Patients with Advanced Non-Small-Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Mutation: Review of the Evidence,” Lung Cancer, Vol. 71, No. 3, 2011, pp. 249-257. doi:10.1016/j.lungcan.2010.12.008

has been cited by the following article: